Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Eriksson, M.

Refine Results

Resource Type

Availability

Creation Date

Show more

Author

Show more

Language

Search results

  • RSS Feed
(61 - 79 of 79)

Pages

Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer
Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer
EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment
Fine-Scale Mapping of the 5q11.2 Breast Cancer Locus Reveals at Least Three Independent Risk Variants Regulating MAP3K1
Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk
Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade
Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium
MicroRNA Related Polymorphisms and Breast Cancer Risk
Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation
A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46 450 cases and 42 461 controls from the breast cancer association consortium
FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium
Molecular and clinical characterization of 25 individuals with exonic deletions of NRXN1 and comprehensive review of the literature
Benefits and Adverse Events in Younger Versus Older Patients Receiving Neoadjuvant Chemotherapy for Osteosarcoma: Findings From a Meta-Analysis
Adjuvant therapy in primary GIST: state-of-the-art
Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Gastrointestinal stromal tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
EURAMOS-1 study: Recruitment, characteristics, and initial treatment of more than 2,000 patients (pts) with high-grade osteosarcoma

Pages